<?xml version="1.0" encoding="UTF-8"?>
<p>Colorectal cancer is considered as the third most common cancer in the world and is in the second position for cancer-related death of humans worldwide (
 <xref rid="B25" ref-type="bibr">Siegel et al., 2017</xref>). It is a multi-stage process that gradually develops with the initiation of transformation in normal colon tissue to an adenomatous intermediate by the consequences of mutation, epigenetic changes, DNA damage, uncontrolled growth with gene and chromosomal instability as well as defects leading to invasive adenocarcinoma (
 <xref rid="B35" ref-type="bibr">Zhang et al., 2011</xref>). It is imperative to understand the appropriate mechanism of prognosis, pathogenesis, and genomic alterations associated with colorectal cancer for the development of appropriate therapeutic strategies.
</p>
